Molecules 2013, 18
3913
1 H, J = 8.6, 15.9 Hz), 1.84 (s, 3 H), 1.52 (s, 3 H), 1.31 (s, 3 H). 13C-NMR (CDCl3, 75 MHz): (ppm)
175.43, 170.35, 138.31, 138.06, 137.88, 137.50, 128.47, 128.43, 128.36, 128.17, 128.04, 127.97,
127.89, 127.86, 127.81, 127.56, 133.13, 104.17, 79.80, 77.20, 76.86, 76.45, 75.66, 74.84, 74.47, 73.33,
73.05, 72.24, 71.84, 71.50, 69.45, 68.40, 68.16, 36.25, 26.98, 26.81, 26.61, 20.98. [α]2D5 +50.97° (c 4.52
+
in CHCl3). HR-MS(ESI), m/z, 849.34625 [M+Na]+ (C47H54NaO13 , requires 849.34621), 871.32809
+
[M−H+Na2]+ (C47H534Na2O13 , requires 871.32816).
2-[3-O-(5-O-Acetyl-3-O-benzyl-1,2-O-isopropylidene-6-deoxy-α-D-allofuranos-6-yl)-2,4,6-tri-O-benzyl-
α-D-mannopyranosyl]-N-[2-amino-6-(benzyloxy)-5-nitrosopyrimidin-4-yl]acetamide (19). To a solution
of acid 18 (0.470 g, 0.57 mmol) in CH2Cl2 (4 mL) was added oxalyl chloride (0.15 mL, 1.7 mmol)
followed by a drop of DMF at 0 °C. The resulting mixture was stirred for 1 h and concentrated in
vacuo. The crude acid chloride was pure according to its NMR spectra and used directly for next step.
IR (cm−1, CHCl3): 3031 (vw), 2932 (vw), 2868 (vw), 1798 (m), 1740 (s), 1496 (w), 1454 (m), 1371
(m), 1234 (s), 1091 (s), 1069 (s), 1023 (s). 1H-NMR (CDCl3, 300 MHz): (ppm) 7.36–7.24 (m, 20 H,),
5.61 (d, 1 H, J = 3.7 Hz), 5.23 (dd, 1 H, J = 6.0, 10.0 Hz), 4.95 (d, 1 H, J = 11.0 Hz), 4.73–4.31 (m, 9 H),
4.10 (dd, 1 H, J = 5.4, 8.9 Hz), 3.97 (t, 1 H, J = 5.8 Hz), 3.86 (dd, 1 H, J = 4.3, 8.8 Hz), 3.81–3.67 (m,
4 H), 3.64–3.57 (m, 3 H), 3.21–3.14 (m, 1 H), 2.99–2.90 (m, 1 H), 1.84 (s, 3 H), 1.52 (s, 3 H), 1.31 (s,
13
3 H). C-NMR (CDCl3, 75 MHz): (ppm) 171.27, 170.22, 138.39, 137.93, 137.54, 137.48, 128.55,
128.48, 128.34, 128.16, 128.02, 127.99, 127.84, 127.77, 127.52, 113.12, 104.13, 79.89, 77.32, 77.23,
76.30, 75.93, 75.25, 74.78, 74.64, 73.34, 72.56, 72.23, 71.74, 71.21, 69.72, 68.25, 67.23, 49.09, 26.82,
26.61, 20.95, 13.97. [α]2D5 +43.68° (c 2.35 in CHCl3).
To a solution of 2,4-diamino-5-nitrosopyrimidine 9 (0.21 g, 0.86 mmol) and pyridine (0.07 mL) in
dry THF (12 mL) was added the above acid chloride (0.47 g, 0.57 mmol) in THF (7 mL) at 0 °C
dropwise. Once the acid chloride was added, the deep-blue solution turned green. After stirring for 1 h,
the purple solid was filtered off, and the filtrate was concentrated in vacuo to afford the amide 19 (600 mg).
IR (cm−1, CHCl3): 3328 (w), 3228 (w), 3031 (w), 2933 (w), 2870 (w), 1739 (m), 1631 (m), 1598 (s),
1535 (s), 1497 (m), 1454 (s), 1371 (m), 1347 (s), 1255 (s), 1209 (s), 1091 (s), 1072 (s), 1026 (s).
1H-NMR (CDCl3, 300 MHz): (ppm) 12.38 (br. s, 1 H, exchange with D2O), 7.51–7.23 (m, 20 H), 7.17
(br. s, 1 H, exchange with D2O), 6.03 (br. s, 1 H, exchange with D2O), 5.65 (d, 1 H, J= 3.7 Hz), 5.63
(s, 2 H), 5.27 (dd, 1 H, J = 5.8, 10.0 Hz), 4.70 (d, 1 H, J = 11.0 Hz), 4.64 (d, 1 H, J = 11.6 Hz), 4.63
(d, 1 H, J = 11.8 Hz), 4.57–4.43 (m, 6 H), 4.14 (dd, 1 H, J = 5.5, 8.9 Hz), 4.06 (br. s, 1 H), 3.88 (dd, 1 H,
J = 4.3, 8.9 Hz), 3.83–3.65 (m, 7 H), 2.97 (dd, 1 H, J = 5.3, 14.7 Hz), 2.89 (dd, 1 H, J = 7.6, 14.9 Hz),
1.83 (s, 3 H), 1.51 (s, 3 H), 1.32 (s, 3 H). 13C-NMR (CDCl3, 75 MHz): (ppm) 171.45, 170.35,
163.78, 138.91, 138.31, 138.04, 137.86, 137.46, 135.49, 128.64, 128.46, 128.44, 128.32, 128.26,
128.20, 128.06, 127.95, 127.80, 127.72, 127.51, 113.12, 104.15, 79.92, 77.33, 77.24, 76.20, 76.05,
74.74, 74.12, 73.13, 72.25, 71.91, 71.62, 69.40, 68.72, 68.62, 41.33, 26.72, 26.61, 20.97. [α]2D5 +81.92°
+
(c 0.053 in CHCl3). HR-MS (ESI), m/z, 1076.4270 [M+Na]+ (C58H63N5NaO14 , required 1076.4264).
8-[(3-O-((5-O-Acetyl-3-O-benzyl-1,2-O-isopropylidene-6-deoxy-α-D-allofuranos-6-yl)-2,4,6-tri-O-benzyl-
α-D-mannopyranosyl)methyl]-O6-benzylguanine (6). A mixture of the amide 19 (600 mg, 0.57 mmol)
and triphenyl phosphine (449 mg, 1.71 mmol) in xylene was stirred at 140 °C overnight and then
cooled to room temperature. The mixture was passed through silica gel (EtOAc/cyclohexane 1/1→1/0)